Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Recent Developments in the Rorschach Inkblot Method

    View: 226

    Website http://www.mentorhealth.com/control/w_product/~product_id=801364LIVE?ourglocal_aug_2018_SEO | Want to Edit it Edit Freely

    Category Rorschach Inkblot Method;Performance Assessment System

    Deadline: August 29, 2018 | Date: August 30, 2018

    Venue/Country: Online, U.S.A

    Updated: 2018-07-12 18:10:37 (GMT+9)

    Call For Papers - CFP

    Training Options Duration: 60 Minutes

    Thursday, August 30, 2018 | 10:00 AM PDT | 01:00 PM EDT

    Overview: This webinar provides an overview of recent developments in the Rorschach

    Inkblot method, specifically in terms of (a) its current research base, (b) comparison between

    the Comprehensive System and the Rorschach Performance Assessment System (R-PAS), and (c)

    considerations in selecting appropriate normative data.

    The webinar will provide a brief review of several aspects of contemporary Rorschach research,

    including interrater and test-retest reliability, as well as validity.

    In addition, you may be unsure about the specific differences between Exner's Comprehensive

    System (CS) and R-PAS. This webinar will detail several key differences between these two

    Rorschach systems and the implications of these differences.

    Selection of appropriate normative data is crucial for interpreting Rorschach results. Without

    normative data, clinicians and researchers are unable to determine whether the results of a

    particular Rorschach variable are considered to be within normal limits, higher than expected,

    or lower than expected. There are several norms available for Exner's Comprehensive System, as

    well as norms for R-PAS.

    A number of considerations will be reviewed in deciding which norms to use and how to use them

    once a particular set of norms have been selected. Even if one selects one of the available

    norms for Exner's comprehensive system, a number of options are available in selecting

    appropriate cutoff scores. In addition, two sets of normative data have recently been presented

    by Choca and colleagues, making the selection of norms a thorny issue for practitioners and

    researchers. This webinar will provide an overview of the relevant issues to consider in

    selecting normative data for interpretive purposes.

    Why should you Attend: Do you have questions about the research foundation for the Rorschach?

    Specifically, you may be wondering whether the Rorschach's reliability, validity, and normative

    meet rigorous standards for psychological testing.

    Are you interested in learning about the primary Rorschach systems used in contemporary

    clinical work? There are two primary systems currently in use: (a) Exner's Comprehensive System

    (CS) , and (b) the Rorschach Performance Assessment System (R-PAS). In addition, Choca and

    colleagues have recently presented a "Basic Rorschach" system.

    Are you confused about which normative data you should use in interpreting Rorschach protocols

    of your patients? There are several options, including the ones that are used in Exner's (2000;

    2003) interpretive guidelines, the "International Norms," and R-PAS norms. In addition, Choca

    and colleagues have recently provided alternative sets of norms, one of which is based on non-

    patient data and the other which is based on a psychiatric sample.

    This webinar provides an overview that addresses these questions.

    Areas Covered in the Session:

    Reliability and validity of the Rorschach

    Options in selecting normative data for interpretation of the Rorschach

    Similarities and differences of the Comprehensive System and the Rorschach Performance

    Assessment System (R-PAS)

    Who Will Benefit:

    Social Work

    Psychology

    Psychiatry

    Speaker Profile

    Marc J. Diener, PhD is an Associate Professor in the Clinical Psychology Doctoral Program at

    Long Island University—Post, and he maintains an independent clinical practice. He earned his

    doctorate in clinical psychology from Adelphi University, and he trained at both Bellevue

    Hospital and St. Luke's Roosevelt Hospital Center. He completed a postdoctoral fellowship at

    The Addiction Institute of New York/St. Luke’s Roosevelt Hospital Center. Prior to joining the

    faculty at Long Island University—Post, he was a faculty member at the American School of

    Professional Psychology, Washington, DC. He has published widely, including peer-reviewed

    journal articles, book chapters, and other publications. He serves as a consulting editor for

    several journals, and his professional presentations include peer-reviewed and invited talks.

    He is a Fellow in the Division of Independent Practice of the American Psychological

    Association. In his clinical practice, he provides psychological testing, individual

    psychotherapy, and supervision/consultation.

    Price - $139

    Contact Info:

    Netzealous LLC - MentorHealth

    Phone No: 1-800-385-1607

    Fax: 302-288-6884

    Email: supportatmentorhealth.com

    Website: http://www.mentorhealth.com/

    Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/

    Follow us on : https://www.facebook.com/MentorHealth1

    Follow us on : https://www.linkedin.com/company/mentorhealth/

    Follow us on : https://twitter.com/MentorHealth1


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.